Ari Mendell, MSc, PhD
Associate Director, Value Communications
Expertise:
In his role as Associate Director, Ari supports all aspects of value communications at EVERSANA, including GVDs, AMCP dossiers, structured/targeted literature reviews and summary slide decks, manuscripts, value propositions, and payer objection handlers.
Ari Mendell holds MSc and PhD degrees in Biomedical Sciences and Neuroscience from the University of Guelph, where he gained extensive research and medical writing experience in the fields of neuroscience and endocrinology. Upon completion of his PhD, Ari was awarded the Governor General’s Gold Medal—one of the highest doctoral academic convocation honors in Canada. Ari’s areas of specialization at EVERSANA include the development of global value dossiers, Academy of Managed Care Pharmacy (AMCP) dossiers, peer-reviewed manuscripts, value story slide decks, objection handlers, and other value communication materials, as well as the conduct of structured and targeted literature reviews. Ari has experience across a variety of therapeutic areas, including acute myeloid leukemia, overactive bladder, melanoma, febrile neutropenia, large B-cell lymphoma, cardiovascular disease, inflammatory bowel disease, Alzheimer’s disease, and psoriasis, among others. He is a member of the American Medical Writers Association.
Articles by Ari Mendell, MSc, PhD
Considering Commercial Success During Clinical Development: Maintaining a Global Perspective
Although commercial success is the ultimate goal of pharmaceutical research and development (R&D), many new treatments do not meet expectations and fail to achieve broad global reimbursement after initial regulatory approval., This causes therapies to underperform across international markets and, more importantly, limits access for patients in need. For example, only 56% of all new drugs approved by the European Medicines Agency (EMA) […]